Acrux Scores Fourth FDA Approval, Nitroglycerin Ointment Moving Into Commercialisation

The Market HeraldDec 12 22:58 ET

Acrux Ltd: FY24 R&D Tax Incentive rebate received

ASXOct 1 18:53 ET · Announcements

Acrux Ltd: Investor Webinar Information - FY24 Results

Aug 28 20:03 ET · Announcements

Acrux Ltd: FY24 Full Year Results - Investor Presentation

Aug 28 20:02 ET · Announcements

Acrux Ltd: Appendix 4E and FY24 Full Year Statutory Accounts

Aug 28 19:59 ET · Announcements

Acrux Secures AU$1.5 Million Funding Facility; Shares Fall 3%

MT NewswiresJun 27 22:19 ET